scholarly journals Giant basal cell carcinoma

2012 ◽  
Vol 87 (3) ◽  
pp. 469-471 ◽  
Author(s):  
Nilton Nasser ◽  
Nilton Nasser Filho ◽  
Bruno Trauczynski Neto ◽  
Lissandra Melati da Silva
Keyword(s):  
Surgical Treatment ◽  
Local Recurrence ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Rare Form ◽  
Common Skin ◽  
The Right ◽  
Giant Basal Cell Carcinoma

The basal cell carcinoma is the most common skin cancer but the giant vegetating basal cell carcinoma reaches less than 0.5 % of all basal cell carcinoma types. The Giant BCC, defined as a lesion with more than 5 cm at its largest diameter, is a rare form of BCC and commonly occurs on the trunk. This patient, male, 42 years old presents a Giant Basal Cell Carcinoma which reaches 180 cm2 on the right shoulder and was negligent in looking for treatment. Surgical treatment was performed and no signs of dissemination or local recurrence have been detected after follow up of five years.

scholarly journals Basal Cell Carcinoma with Disseminated Bone Metastization: An Unusual Outcome of the Most Common Malignancy

2021 ◽  
Vol 79 (3) ◽  
pp. 261-264
Author(s):  
Luísa Rolim ◽  
Bruno M. Fernandes ◽  
Carolina Carvalho ◽  
António Silva ◽  
Joana Calvão ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Survival Rates ◽  
Palliative Radiotherapy ◽  
High Morbidity ◽  
Common Skin ◽  
Metastatic Basal Cell Carcinoma ◽  
Low Incidence ◽  
The Right

Basal cell carcinoma is the most common skin cancer, with a very low incidence of metastases, associated with high morbidity and mortality. The morpheaform clinical variant is uncommon, presenting an aggressive growth pattern. Early diagnosis and new targeted therapies for metastatic disease are important to improve survival rates. We present the case of a 29-year-old patient with morpheaform basal cell carcinoma in the right genian region. Due to local recurrences, he underwent surgery and adjuvant radiotherapy. For extensive metastatic bone involvement, the patient started vismodegib and, later, pembrolizumab, and also performed palliative radiotherapy. Despite several lines of systemic therapy, the disease progressed, and the patient died after 8 years of follow-up. This case shows how crucial it is to identify risk factors for metastatic basal cell carcinoma and highlights the need to improve target therapies and tailor them to the patient’s biological profile.

scholarly journals Giant Basal Cell Carcinoma – a Case Report

2018 ◽  
Vol 10 (3) ◽  
pp. 83-89
Author(s):  
Igor Kapetanović ◽  
Vesna Reljić ◽  
Martina Bosić ◽  
Svetlana Popadić
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Slow Growth ◽  
Rare Type ◽  
Basal Cell Carcinomas ◽  
The Right ◽  
Electron Radiotherapy ◽  
Giant Basal Cell Carcinoma ◽  
Cutaneous Cancer

Abstract Basal cell carcinoma is the most common form of cutaneous cancer. In majority of cases it is locally invasive with slow growth, ranging in size from a couple of milimeters to a couple of centimeters and located primarily on sun-exposed regions. Giant basal cell carcinoma, defined as a tumor that is larger than 5 cm in diameter, is a very rare type of cutaneous malignancy accounting for 0.5-1% of all basal cell carcinomas. We present a case of a 74-year-old man with a 17 x 14 cm giant basal cell carcinoma in the right supraclavicular region. Detailed history revealed that the lesion had started as a papule 15 years before presentation. Despite its growth, the lesion was neglected until admission. Histological examination of skin lesion confirmed superficial and focally infiltrative types of basal cell carcinoma. Electron radiotherapy was administered with 54 Gy total dose delivered in 20 daily fractions which resulted in healing of lesions and adequate response. Thus, definitive radiotherapy can be just as effective as excision when the criteria are met.

scholarly journals A study of Basal cell carcinoma: An adequate follow-up period after surgical treatment

Skin Cancer ◽  
2005 ◽  
Vol 20 (3) ◽  
pp. 291-295
Author(s):  
Emiko TAKEISHI ◽  
Takashi DOI ◽  
Shinichi SATO ◽  
Ryoji HIROSE
Keyword(s):  
Surgical Treatment ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell

Aggressive progression of a facial super giant basal cell carcinoma

2021 ◽  
Vol 14 (4) ◽  
pp. e240617
Author(s):  
Athina Lidia Yoham ◽  
Hadeer Sinawe ◽  
Jack Schnur ◽  
Damian Casadesus
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Vision Loss ◽  
Temporal Area ◽  
Orbital Roof ◽  
The Face ◽  
Lost To Follow Up ◽  
Giant Basal Cell Carcinoma

Super giant basal cell carcinoma (BCC) is a rare oncological entity. A 52-year-old man with a history of a left upper facial lesion for 11 years was transferred to our facility seeking an evaluation. He frequented multiple hospitals where he was treated with antibiotics for this condition. He reported having the Mohs procedure 8 months prior to this hospital visit but he did not follow-up with the other institution. The physical examination revealed an ulcer involving the upper left orbito-fronto-parieto-temporal area with bone exposure. Both CT and MRI of the face and the brain demonstrated dehiscence of the left lateral orbital roof and left frontal bone. The biopsy confirmed advanced BCC. He was discharged against medical advice and lost to follow-up. He returned 1 month later with left eye discharge and vision loss. He was diagnosed with cerebral abscess, treated with antibiotics and discharged to hospice.

Long-Term Results after Treatment of Basal Cell Carcinoma of the Eyelid in Southwestern Finland

2007 ◽  
Vol 17 (4) ◽  
pp. 494-500 ◽  
Author(s):  
V. Paavilainen ◽  
J. Tuominen ◽  
V.V. Aho ◽  
K.M. Saari
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Recurrence Rate ◽  
Basal Cell ◽  
Long Term Results ◽  
White Population ◽  
Common Skin ◽  
The Mean

Purpose Basal cell carcinoma (BCC) is the most common skin cancer of the eyelid, showing an increasing incidence in the white population. The authors studied the clinical characteristics and the treatment results of BCC of the eyelid in southwestern Finland during 1977–1997. Methods The authors reviewed the case records of 191 patients with BCC of the eyelids treated at the Turku University Eye Clinic during 1977–1997. The mean follow-up period after the treatment was 8.6±5.2 years. Results The 191 patients had altogether 194 BCC tumors of the eyelid with the mean diameter of the tumor being smaller than 10 mm in 77.3% of cases. Of the 194 BCC tumors of the eyelid 16.0% showed recurrence, and the recurrence rate of all surgically treated tumors was 13.7%. In this study 61 patients (31.9%) developed other malignancies than the BCC of the eyelid including 28 patients (14.7 %) with carcinoma in other locations than skin. Conclusions Incompletely removed BCCs of the eyelid showed only 18.9% recurrence rate during the follow-up time. On the other hand, BCCs of the eyelid should not be underestimated because of the rather high total recurrence rate. The frequency of 31.9% of other malignancies than BCC of the eyelid is remarkably high and requires special attention from the ophthalmologist taking care of the patient with BCC of the eyelid.

scholarly journals Super giant basal cell carcinoma in an autistic patient: A case report

2020 ◽  
Vol 8 ◽  
pp. 2050313X2093948
Author(s):  
Emma Hudson ◽  
Mohannad Abu Hilal
Keyword(s):  
Case Report ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Anterior Chest Wall ◽  
Increased Risk ◽  
Common Skin ◽  
Impaired Quality ◽  
Giant Basal Cell Carcinoma

Basal cell carcinoma is the most common skin cancer in the world and is generally treated when small in size with an excellent prognosis. Rarely, basal cell carcinoma will grow to be larger than 5 cm, at which point they are termed giant basal cell carcinoma. Giant basal cell carcinoma comprises only 0.5% of all basal cell carcinoma, but is associated with impaired quality of life and increased risk of metastasis. When a basal cell carcinoma grows to over 20 cm in size, it is termed super giant basal cell carcinoma. Here, we report a case of both a super-giant basal cell carcinoma and a giant basal cell carcinoma developing over 10–12 years on the upper back and anterior chest wall of an autistic male. Generally, this presentation is associated with neglect on the part of the patient. This case report demonstrates a super-giant basal cell carcinoma developing secondary to patient neglect in the context of comorbid mental illness.

Two Cases of Giant Basal Cell Carcinoma of the Vulva

2005 ◽  
Vol 67 (6) ◽  
pp. 584-589 ◽  
Author(s):  
Tadamasa YAMAMOTO ◽  
Sachiko TAKEICHI ◽  
Daisuke FUKUMOTO ◽  
Hirotsugu TAKIWAKI ◽  
Seiji ARASE ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Giant Basal Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document